NCT00077402 - Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

January 31, 2011

Study Completion Date

February 28, 2011

Conditions

Prostate Cancer

Interventions

DRUG

fenretinide

Trial Locations (6)

Sydney Cancer Centre at Royal Prince Alfred Hospital, Sydney

Sir Charles Gairdner Hospital - Perth, Perth

Cancer Institute at National University Hospital, Singapore

National Cancer Centre - Singapore, Singapore

Johns Hopkins Singapore International Medical Centre, Singapore

Prince of Wales Hospital, Shatin, New Territories